Keywords: actelion, reports, strong, early, data, sleep, drug
Actelion reports strong early data on sleep drug
Article | 05 February 2007
Swiss drugmaker Actelion says that preclinical and placebo-controlled clinical trial data were published in the February edition of Nature Medicine ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
